Subscribe To

Price Alert Latest News Economic Calendar News

PMEDF / Predictmedix forges ahead with commercialization plans for its AI-powered technology suite in Asia

Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) a provider of rapid health screening solutions, revealed that it is making significant strides in the commercialization of its artificial intelligence (AI) product suite in key Asian markets. The Toronto-based company said it has advanced its ongoing partnership with a top Indonesian university, as it goes through the validation process for regulatory approval of its AI-product suite as a medical device in Indonesia. Read More

Demo Live Account See Partner Details

Content Topics

Predictmedix

Forges

Ahead

With

Commercialization

Plans

Ai powered

Technology

Stock

PMEDF

Posted: Jun 13 2023, 09:52

Author Name: Proactive Investors

PMEDF News

By Proactive Investors
November 2, 2023

Predictmedix AI to showcase impairment screening technology at 30-country summit in India

Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) told investors it has been invited to showcase its innovative impairment screening technology at the D-30

By Proactive Investors
October 27, 2023

Predictmedix AI accelerates business development initiatives during international campaign

Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) said it has returned from a month-long international campaign during which it achieved numerous corporate

By Proactive Investors
September 20, 2023

Predictmedix AI executives head to India for strategic collaborations

Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) told investors its executive team is going on a strategic visit to India this weekend to engage with inst

By Proactive Investors
September 6, 2023

Predictmedix AI sets the pace in AI-driven healthcare with strong 2023 start

Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) said it is “poised to lead the charge in AI-driven healthcare solutions” after a strong start to 2023

By Proactive Investors
August 21, 2023

Predictmedix AI says its AI product suite can now detect early signs of diabetes

Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) said its artificial intelligence (AI) product suite can now detect early signs of diabetes by analyzing s

By Proactive Investors
August 2, 2023

Predictmedix AI surpasses 200,000 scans with AI-powered Safe Entry Stations

Predictmedix AI Inc revealed it had surpassed 200,000 individual scans through its AI-powered Safe Entry Stations. The stations, equipped with advance

By Proactive Investors
July 28, 2023

Predictmedix AI unveils significant progress in Indonesia

Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) has announced significant progress in its efforts to introduce Safe Entry Stations (SES) into Indonesia'

By Proactive Investors
July 25, 2023

Predictmedix AI partners with Indian supplier to mass produce AI-powered Safe Entry stations

Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) said its fully owned Indian subsidiary, Predictmedix India Private Ltd, has engaged an Indian supplier fo

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.